RVMD
Revolution Medicines Inc
NASDAQ: RVMD · HEALTHCARE · BIOTECHNOLOGY
$140.55
-2.96% today
Updated 2026-04-29
Market cap
$29.88B
P/E ratio
—
P/S ratio
9,035.10x
EPS (TTM)
$-5.95
Dividend yield
—
52W range
$34 – $156
Volume
3.1M
Revolution Medicines Inc (RVMD) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0.00 | $20.16M | $50.04M | $42.98M | $29.39M | $35.38M | $11.58M | $0.00 | $0.00 |
| Revenue growth (YoY) | — | — | +148.2% | -14.1% | -31.6% | +20.4% | -67.3% | -100.0% | — |
| Cost of revenue | $26.59M | $51.08M | $91.75M | $132.25M | $186.95M | $253.07M | $411.24M | $592.23M | $16.56M |
| Gross profit | $-26.59M | $20.16M | $50.04M | $42.98M | $29.39M | $35.38M | $11.58M | $-592.23M | $-16.56M |
| Gross margin | — | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | — | — |
| R&D | $26.59M | $51.08M | $91.75M | $132.25M | $186.95M | $253.07M | $423.14M | $592.23M | $978.68M |
| SG&A | $4.54M | $9.41M | $12.41M | $21.43M | $30.45M | $40.59M | $75.62M | $97.30M | $187.13M |
| Operating income | $-31.13M | $-40.33M | $-54.12M | $-110.70M | $-188.01M | $-258.28M | $-487.19M | $-689.52M | $-1.18B |
| Operating margin | — | -200.0% | -108.2% | -257.5% | -639.7% | -730.0% | -4207.1% | — | — |
| EBITDA | $-29.84M | $-39.91M | $-48.59M | $-101.91M | $-179.75M | $-248.62M | $-477.88M | $-677.70M | $-1.09B |
| EBITDA margin | — | -197.9% | -97.1% | -237.1% | -611.6% | -702.7% | -4126.7% | — | — |
| EBIT | $-31.02M | $-41.67M | $-51.93M | $-108.46M | $-187.08M | $-258.28M | $-487.19M | $-689.52M | $-1.11B |
| Interest expense | $103000.00 | $116000.00 | $106000.00 | $71000.00 | $12000.00 | $9.66M | $303000.00 | $0.00 | $24.23M |
| Income tax | — | — | — | — | — | — | — | — | — |
| Effective tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | $-31.13M | $-41.79M | $-47.66M | $-108.16M | $-187.09M | $-248.71M | $-436.37M | $-600.09M | $-1.13B |
| Net income growth (YoY) | — | -34.3% | -14.1% | -126.9% | -73.0% | -32.9% | -75.5% | -37.5% | -88.5% |
| Profit margin | — | -207.2% | -95.2% | -251.6% | -636.6% | -703.0% | -3768.3% | — | — |